Featured Posts
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Citation
FDA approval for “biogeneric” drugs
Newsletter
Hurricane Recovery, Union Politics and Disaster Insurance
Residents of the hurricane-ravaged Gulf Coast are being advised to avoid taps and drink only bottled water. Unions increase their spending on campaign advertisements and…
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.
Op-Eds
CAFE Oh Nay, Standard Has Hurt
The Detroit auto industry is clearly a victim of CAFE. But it’s not the only victim, and it’s not even the most prominent one.
Newsletter
Stem Cells, Regulating Lawn Mowers and Standing up to the SEC
The National Academy of Sciences argues for continued use of embryonic stem cells. The Environmental Protection Agency requires that new gas-powered lawn mowers come with…
Newsletter
Economic Projections, Comcast Sues the FCC and Cholesterol Drugs
A new report from the Federal Reserve projects continued slow growth and a weak business climate. Comcast sues the Federal Communications Commission over…